InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,622.40
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.09
(
-0.94%
)
Bitcoin
62,331.29
(
0.00%
)
Post# of 4856
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BesaoT35

Send PM Follow Ignore
Followers 7
Posts 861
Boards Moderated 0
Alias Born 07/08/2013

BesaoT35

Re: None

Thursday, 12/17/2020 4:24:34 PM

Thursday, December 17, 2020 4:24:34 PM

Post# of 4856
CUR used to have a drug in clinical trials called NSI-189. It was a small molecule that does easily cross the blood brain barrier. It has been shown anatomically that it would cause neural growth in the hippocampus. It did show cognitive benefits for patients but missed the mood related psychological endpoints in a depression trial.

I thought that the drug still had potential. I do not however see any recent news about NSI-189. Does any one know anything that they could share about the current status or the potential clinical benefits of NSI-189? Thanks.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up